Feature|Articles|April 1, 2026
Top 10 urology headlines you missed in Q1 2026
Author(s)Hannah Clarke
Fact checked by: Benjamin P. Saylor, Strategic Content Lead
Take a look through the top 10 stories in urology from the past quarter.
Advertisement
Advertisement
The first quarter of 2026 brought a wave of pivotal developments across urology, from landmark clinical trial results to meaningful FDA actions reshaping treatment standards. Bladder and prostate cancer saw some of the most significant advances, with the KEYNOTE-B15 trial establishing a new perioperative standard of care in muscle-invasive disease and the PRIMARY2 trial offering a smarter diagnostic path that could spare men from unnecessary biopsies.
Advertisement
Advertisement